Nextra® Hammertoe Correction System

Nextra Hammertoe Correction System is the industry’s only adjustable two-piece hammertoe solution. It offers a stable, secure implant with 10 degrees of angulation to allow for a natural position of the toe after implantation. The two-piece design with RevLock® Adjustable Locking Mechanism provides intermediate locking before final closure and allows for retained compression.

  • Maximized bone purchase1
  • Stable and secure phalanx
  • Optimized screw design
  • Adjustable bone-to-bone apposition
    • Progressive ratchet tightening mechanism
    • Aids bone fusion
  • 2-Piece precision insertion
    • Intermediate locking before final closure
  • Reversible assembly
    • Proprietary RevLock Adjustable Locking Mechanism
  • Natural anatomically correct design with 10° angulation
  • 2-piece Design / 10 Degrees Angulation
  • 3 Sizes for Density and Width: 3.5mm, 4.5mm, 5.5mm
  • No Pin Tract Infection Risk
  • Superior Bone Purchase vs. K-wires2
  • Healthy Joints not Disrupted (DIPJ)
  • Adjustable In Situ
  • Removable at Surgery
    • Ability to revise if position is not optimal
  • Internal Stability
  • Precision leading to Predictable and Reproducible Results2
  • RevLock Adjustable Locking Mechanism
    • Retains Compression
    • Provides Adjustability and Control
    • Implant is completely Reversible
  • Nextra Hammertoe Correction System versus Standard of Care - Kirschner Wires2:
    • 5.8 X higher rate of bone fusion
    • 80% decreased gap
    • 12% increase in quality of life
    • 9% decrease in pain
    • 22% greater decrease in patients’ level of disability
    • 88% increase in activity improvement
  1. ”Achieving Maximum Phalangeal Fixation and Bone Contact through Osteological Design of Hammertoe Implants”; Osteological study of bone purchase for the Nextra Hammertoe Implant.
  2. Jay RM, Malay DS, Landsman AS, Jennato N, Huish J, Younger M. “Dual-Component Intramedullary Implant versus Kirschner Wire for Proximal Interphalangeal Joint Fusion: A Randomized Controlled Clinical Trial”- The Journal of Foot & Ankle Surgery 55 (2016); 697-708.


Nextra® and RevLock® are trademarks of Nextremity Solutions, Inc.


Legal Manufacturer:

210 N. Buffalo St.
Warsaw, IN 46580 U.S.A.

This material is intended for health care professionals.  Distribution to any other recipient is prohibited.  For indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert or contact your local representative; visit for additional product information.
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
Not all products shown herein are available in all regions; check for product country clearances and reference product-specific instructions for use.
Talk to your surgeon about whether joint replacement or another treatment is right for you and the risks of the procedure, including the risk of implant wear, loosening or failure, and pain, swelling and infection. Zimmer Biomet does not practice medicine; only a surgeon can answer your questions regarding your individual symptoms, diagnosis and treatment.